T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.84B |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.13B |
| 3 |
Elanco Animal Health
ELAN
|
+$1.1B |
| 4 |
Bank of America
BAC
|
+$860M |
| 5 |
JB Hunt Transport Services
JBHT
|
+$618M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.19B |
| 2 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
+$1.55B |
| 3 |
JPMorgan Chase
JPM
|
+$1.29B |
| 4 |
Booking.com
BKNG
|
+$1.06B |
| 5 |
Merck
MRK
|
+$757M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.47% |
| 2 | Healthcare | 18.48% |
| 3 | Consumer Discretionary | 13.62% |
| 4 | Financials | 13.47% |
| 5 | Communication Services | 10% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MIME
1276
DELISTED
Mimecast Limited
MIME
| $13M | ﹤0.01% |
274,866
+108,879
| +66% | +$4.58M |
|
1277
CareDx
CDNA
$3.34B
| $12.8M | ﹤0.01% |
405,718
+85,030
| +27% | +$2.48M |
|
1278
Axalta
AXTA
$6.99B
| $12.8M | ﹤0.01% |
507,160
+33,112
| +7% | +$852K |
|
1279
Zai Lab
ZLAB
$2.88B
| $12.7M | ﹤0.01% |
431,132
-519,288
| -55% | -$14.2M |
|
1280
Capri Holdings
CPRI
$1.68B
| $12.6M | ﹤0.01% |
275,495
+15,640
| +6% | +$684K |
|
|
PHX
1281
DELISTED
PHX Minerals
PHX
| $12.6M | ﹤0.01% |
801,424
-125,348
| -14% | -$2M |
|
|
SFE
1282
DELISTED
Safeguard Scientifics, Inc.
SFE
| $12.4M | ﹤0.01% |
1,143,275
-104,431
| -8% | -$1.06M |
|
1283
Minerva Neurosciences
NERV
$162M
| $12.4M | ﹤0.01% |
196,731
+9,650
| +5% | +$580K |
|
1284
Xerox
XRX
$428M
| $12.3M | ﹤0.01% |
385,640
-100
| -0% | -$2.82K |
|
|
SFLY
1285
DELISTED
Shutterfly, Inc.
SFLY
| $12.3M | ﹤0.01% |
302,861
-25,799
| -8% | -$1.13M |
|
1286
BHP
BHP
$215B
| $12.1M | ﹤0.01% |
248,493
+34,384
| +16% | +$1.57M |
|
1287
FS Bancorp
FSBW
$350M
| $11.9M | ﹤0.01% |
472,822
+5,392
| +1% | +$133K |
|
|
ECHO
1288
EchoStar
ECHO
$25.9B
| $11.9M | ﹤0.01% |
403,635
+256
| +0.1% | +$8.07K |
|
|
FOLD
1289
DELISTED
Amicus Therapeutics
FOLD
| $11.7M | ﹤0.01% |
863,345
-1,932
| -0.2% | -$23.6K |
|
|
HBI
1290
DELISTED
Hanesbrands
HBI
| $11.7M | ﹤0.01% |
654,860
+103,000
| +19% | +$1.71M |
|
|
STML
1291
DELISTED
Stemline Therapeutics, Inc.
STML
| $11.5M | ﹤0.01% |
+892,586
| New | +$10.1M |
|
1292
Elastic
ESTC
$9.23B
| $11.4M | ﹤0.01% |
142,867
+107,846
| +308% | +$9.01M |
|
|
KW
1293
DELISTED
Kennedy-Wilson Holdings
KW
| $11.4M | ﹤0.01% |
533,378
+428
| +0.1% | +$8.68K |
|
1294
Cooper-Standard Automotive
CPS
$387M
| $11.2M | ﹤0.01% |
239,354
-24,825
| -9% | -$1.6M |
|
1295
Copa Holdings
CPA
$5.35B
| $11.2M | ﹤0.01% |
139,382
+3,799
| +3% | +$334K |
|
|
FTSV
1296
DELISTED
Forty Seven, Inc. Common Stock
FTSV
| $11.2M | ﹤0.01% |
695,205
-11,865
| -2% | -$188K |
|
1297
Innoviva
INVA
$1.53B
| $11.2M | ﹤0.01% |
798,070
+155,087
| +24% | +$2.51M |
|
1298
Denali Therapeutics
DNLI
$3.35B
| $11.2M | ﹤0.01% |
481,342
+4,100
| +0.9% | +$85.8K |
|
|
CRNX
1299
DELISTED
Crinetics Pharmaceuticals
CRNX
| $11.1M | ﹤0.01% |
486,130
+52,134
| +12% | +$1.28M |
|
|
PBCT
1300
DELISTED
People's United Financial Inc
PBCT
| $11M | ﹤0.01% |
668,998
-5,900
| -0.9% | -$98.3K |
|
Similar funds
T. Rowe Price Associates's Q1 2019 Portfolio in Review
As of Q1 2019, T. Rowe Price Associates held 2,615 positions worth $680B, up 15% from $591B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q1 2019 filing shows 56 new, 1,633 increased, 713 reduced and 86 closed positions. Its largest new stake was Fox Class B: 11,707,204 shares worth $420M. The largest sale was Tesla, an estimated $2.19B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2019 buy was Fox Class B: 11,707,204 shares worth $420M.
- T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q1 2019, an estimated $2.84B increase.
- T. Rowe Price Associates's biggest Q1 2019 reduction was Tesla, cutting an estimated $2.19B.
- T. Rowe Price Associates fully exited Twenty-First Century Fox, Inc. Class B in Q1 2019, selling an estimated $1.55B.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $680B portfolio in Q1 2019.
- T. Rowe Price Associates opened 56 new positions and closed 86 in Q1 2019.
- T. Rowe Price Associates's portfolio value rose 15% quarter-over-quarter to $680B.
Based on T. Rowe Price Associates's 13F filing for Q1 2019, filed 15 May 2019.